Open AccessGemtuzumab Extends Event-free Survival in Children with AML
Author(s) -
Mark Fuerst
Publication year - 2014
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000444058.68880.94
Subject(s) - gemtuzumab ozogamicin , medicine , hematology , cd33 , myeloid leukemia , oncology , chemotherapy , refractory (planetary science) , stem cell , cd34 , physics , genetics , astrobiology , biology